Terms: = Breast cancer AND SRSF3, SRp20, SFRS3, 6428, ENSG00000112081, P84103 AND Treatment
5 results:
1. TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms.
Guo L; Ke H; Zhang H; Zou L; Yang Q; Lu X; Zhao L; Jiao B
Cell Death Dis; 2022 May; 13(5):428. PubMed ID: 35504883
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of analytical accuracy of HER2 status in patients with breast cancer: Comparison of HER2 GPA with HER2 IHC and HER2 FISH.
Jensen SG; Thomas PE; Christensen IJ; Balslev E; Hansen A; Høgdall E
APMIS; 2020 Nov; 128(11):573-582. PubMed ID: 32860265
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of srsf3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract] [Full Text] [Related]
4. The Support, Education, and Advocacy (SEA) Program of Care for Women With Metastatic breast cancer: A Nurse-Led Palliative Care Demonstration Program.
Reiser V; Rosenzweig M; Welsh A; Ren D; Usher B
Am J Hosp Palliat Care; 2019 Oct; 36(10):864-870. PubMed ID: 30974954
[TBL] [Abstract] [Full Text] [Related]
5. Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification.
Chung MH; Wang YW; Chang YL; Huang SM; Lin WS
Oncotarget; 2017 Jul; 8(27):44203-44216. PubMed ID: 28496002
[TBL] [Abstract] [Full Text] [Related]